Association Between the Use of Systemic Steroids and Ocular Hypertension as a Side Effect in Pediatric Population: A Systematic Review.
children
ocular hypertension (oht)
raised intra-ocular pressure
side effects
systemic steroids
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
31
05
2023
accepted:
19
07
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Steroids are commonly used in children for the treatment of various medical conditions. However, systemic steroids can lead to the development of ocular hypertension (OHT), an increase in intraocular pressure. Limited literature is available on the systemic route of steroid administration in children and the development of this side effect. For literature writing and review, a thorough research was conducted across various platforms, such as PubMed, PubMed Central (PMC), Medline, and Cochrane Database of Systematic Reviews (CDSR). After all the screening processes and quality checks, 12 articles were finalized for review writing. The aim was to explore if OHT development is a common side effect developed in children on systemic steroid use for various medical conditions and if any particular risk factors were present among children that lead to its development. The results indicate that OHT is a common side effect of systemic steroid use in children. Children may or may not present with the symptoms of raised intraocular pressure. The development of OHT occurs within one month of the beginning of the steroid treatment in most of the reviewed studies. Several risk factors associated with developing this side effect were also found. In conclusion, systemic steroid use in children leads to the development of OHT. Awareness among healthcare professionals regarding this potential association is necessary. This information can be used to develop guidelines for serial ocular examinations in children on prolonged systemic steroid use.
Identifiants
pubmed: 37602115
doi: 10.7759/cureus.42112
pmc: PMC10438628
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e42112Informations de copyright
Copyright © 2023, Mushtaq et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Int Ophthalmol Clin. 1966 Winter;6(4):929-89
pubmed: 4865223
Br J Ophthalmol. 1998 Jun;82(6):704-8
pubmed: 9797677
Optom Vis Sci. 2021 Aug 1;98(8):867-869
pubmed: 34460447
Paediatr Int Child Health. 2021 Aug;41(3):199-205
pubmed: 34711131
J Glaucoma. 2019 Oct;28(10):929-933
pubmed: 31453897
Am J Ophthalmol. 2004 Jan;137(1):198-201
pubmed: 14700676
J Glaucoma. 2016 Apr;25(4):343-7
pubmed: 25651206
Clin Ophthalmol. 2012;6:1675-9
pubmed: 23097611
Pediatr Blood Cancer. 2014 Nov;61(11):2083-5
pubmed: 25132159
Br J Haematol. 2022 Mar;196(5):1248-1256
pubmed: 34862597
J Pediatr Ophthalmol Strabismus. 2006 Sep-Oct;43(5):311-2
pubmed: 17022166
Am J Ophthalmol. 2019 Jun;202:1-5
pubmed: 30763540
Mol Vis. 2012;18:2001-11
pubmed: 22876128
Lens Eye Toxic Res. 1992;9(3-4):469-82
pubmed: 1301798
Drug Ther Bull. 2019 Oct;57(10):158-159
pubmed: 31444222
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Children (Basel). 2022 Mar 21;9(3):
pubmed: 35327812
Acta Ophthalmol. 2012 Sep;90(6):559-63
pubmed: 21044276
Ophthalmic Res. 2012;47(2):66-80
pubmed: 21757964
Lancet. 1997 Oct 4;350(9083):979-82
pubmed: 9329512
Leuk Res. 2019 Jan;76:24-28
pubmed: 30513404
J Glaucoma. 2010 Mar;19(3):188-90
pubmed: 19661822
Prog Retin Eye Res. 2017 Jan;56:58-83
pubmed: 27666015
Clin Exp Ophthalmol. 2005 Jun;33(3):252-8
pubmed: 15932528
Am J Ophthalmol. 1991 Oct 15;112(4):450-4
pubmed: 1928249
Exp Eye Res. 1978 Nov;27(5):567-75
pubmed: 720430
Am J Respir Crit Care Med. 2012 Dec 15;186(12):1248-55
pubmed: 23065012
Acta Ophthalmol. 2021 Dec;99(8):e1430-e1434
pubmed: 33629533
Surv Ophthalmol. 2002 Nov-Dec;47(6):547-61
pubmed: 12504739
Drugs Aging. 1999 Dec;15(6):439-50
pubmed: 10641955
Indian J Ophthalmol. 1973 Sep;21(3):102-7
pubmed: 4499999
Mol Vis. 2010 Apr 03;16:596-601
pubmed: 20376328
Pediatr Nephrol. 2014 Nov;29(11):2165-71
pubmed: 24859790
Indian J Pediatr. 2014 Jul;81(7):680-3
pubmed: 24557606
Int J Mol Sci. 2019 Jan 21;20(2):
pubmed: 30669566
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):473-85
pubmed: 12556371
Pediatr Blood Cancer. 2019 Dec;66(12):e27977
pubmed: 31489974